Explore CEO insights on decision-making in manufacturing, focusing on risk management, packaging challenges, and strategies for product safety and quality.
Chris Spivey
Advertisement
Articles by Chris Spivey
BioLamina CEO Klaus Langhoff-Roos discusses the challenges of scaling stem cell production from lab plates to bioreactors, emphasizing the balance between cost, risk, and speed in advancing laminin-based technologies that could accelerate next-generation cell and gene therapies.
Chris Spivey, Director of Industrial Relations and Strategic Partnerships for Industry Sciences One at MJH Life Sciences, and Raymond J. Deshaies, PhD, Executive Officer of Molecular Biology at the California Institute of Technology, discuss the development of MariTide, which is in development for obesity and type 2 diabetes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
5
